ICA Group Wealth Management’s Pfizer PFE Stock Holding History

ICA Group Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$239K	Sell	8,545 -15,987	-65%	-$440K	0.14%	91
2024 Q1	$681K	Sell	24,532 -2,769	-10%	-$76.8K	0.14%	141
2023 Q4	$786K	Buy	27,301 +4,281	+19%	+$129K	0.18%	110
2023 Q3	$764K	Buy	23,020 +1,171	+5%	+$41.4K	0.21%	97
2023 Q2	$801K	Sell	21,849 -21,023	-49%	-$818K	0.2%	96
2023 Q1	$1.75M	Sell	42,872 -495	-1%	-$21.4K	0.42%	53
2022 Q4	$2.22M	Sell	43,367 -32,549	-43%	-$1.56M	0.52%	41
2022 Q3	$3.32M	Buy	75,916 +2,646	+4%	+$129K	0.71%	30
2022 Q2	$3.6M	Sell	73,270 -1,739	-2%	-$88.6K	0.67%	32
2022 Q1	$4M	Buy	+75,009	New	+$3.89M	0.76%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ICA Group Wealth Management's PFE Position: Q2 2024 in Review

ICA Group Wealth Management reduced its Pfizer (PFE) stake by 65% in Q2 2024, selling an estimated $440K and leaving 8,545 shares worth $239K. The position accounts for 0.14% of the portfolio, ranked #91.

ICA Group Wealth Management first reported a position in PFE in Q1 2022 and has held it in 10 quarters since. The position peaked at $4M in Q1 2022. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

ICA Group Wealth Management held 8,545 shares of Pfizer worth $239K as of Q2 2024.
ICA Group Wealth Management sold 15,987 Pfizer shares in Q2 2024, an estimated $440K.
Pfizer made up 0.14% of ICA Group Wealth Management's portfolio in Q2 2024, its #91 holding.
ICA Group Wealth Management first reported a position in Pfizer in Q1 2022 and has held it in 10 quarters since.
ICA Group Wealth Management's Pfizer position peaked at $4M in Q1 2022.
2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.